Goldman Sachs analyst Scott Fidel lowered the firm’s price target on Cigna (CI) to $330 from $370 and keeps a Buy rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Cigna price target lowered to $300 from $354 at Wells Fargo
- Cigna price target lowered to $333 from $387 at TD Cowen
- Cigna price target lowered to $330 from $370 at Goldman Sachs
- Cigna’s Strategic Transition and Growth Prospects Justify Buy Rating
- Cigna price target lowered to $350 from $385 at Raymond James